Project Name: Provision of Dermatology Clinical Nurse Specialist, Leeds Dermatology Service

Project Summary:

The main objective of this collaborative working project (CWP) is to improve the quality of care delivered to Psoriasis (PsO) and hidradenitis suppurativa (HS) patients at the trust in line with the National Institute for Clinical Excellence (NICE) and National British Association of Dermatology (BAD) guidelines. This CWP will improve the current hospital-based service at The Trust by deploying a Dermatology Clinical Nurse Specialist (CNS) to the Dermatology department. Additionally, the Trust will establish a business case for future funding of this extension to this service by the NHS. The band 6 Dermatology CNS will be responsible for supporting the current nurse led new patient PsO service at Chapel Allerton Hospital, developing a specialist HS nurse led service and reviewing the severe HS patients including supporting, counselling and changing biologics.

Established Process Mapping methodologies will be used to support with provision of baseline data and integration of the new role into the relevant aspects of the service.

As part of the project, the nurse will complete their Nurse Prescriber Course to further enhance their value and embed them into the Dermatology service.

Planned Milestones:

MilestonesDescription
1Kick off meeting
2Novartis SIM to conduct Pathway Mapping to include involvement from relevant stakeholders within department and 
delivery of a ‘baseline’ service map.
3

Recruitment of Band 6 clinical nurse specialist (CNS)

Collection of Baseline data 

Creation of satisfaction survey

4

Submission of 3 months clinical data

Initation of development of HS Training handbook

5

Submission of 6 months clinical data

6

Submission of 9 months clinical data

7

Submission of 12 months clinical data

8

Submission of 15 months clinical data

9

Submission of 18 months clinical data

10Submission of 21 months clinical data
11

Submission of 24 months clinical data

Completion and submission of business case 

Completion of HS Training handbook

12Novartis SIM to conduct Pathway Mapping to include involvement from relevant stakeholders within department and 
delivery of a ‘developed’ service map
13

Analysis of CWP data and  submission of Final Project Report

Submission of Outcomes Summary 

 

Expected Benefits:

Anticipated benefits for patients:

  • Improved access to diagnosis,treatment and ongoing optimised management of PsO, HS and eczema,
  • More equitable and consistent access to care, 
  • Enhanced experience for patients and their carers who live with PsO, HS and eczema,
  • Access to a bespoke service for HS patients across Yorkshire.

Anticipated benefits for the organisation:

  • Increase the overall quality of care for PsO and HS patients in Yorkshire,
  • Improve equity of access to specialist care for patients with HS, 
  • Decrease patient waiting times,
  • Decrease number of unnecessary out-patient appointments and hospital in-patient stays.

Anticipated benefits for Novartis:

  • Increased appropriate use of licensed medicines in line with NICE guidelines, including Novartis’ therapies,
  • Improved reputation,
  • Improved professional and transparent relationship and trust between Novartis and the NHS

Start Date & Duration: December 2023 for 29 months

UK2312074393